Tafazzin (TAZ) (Middle Region) Peptide
TAZ
Reactivity: Human
Host: Synthetic
BP, WB
Catalog No. ABIN5511601
Quick Overview for Tafazzin (TAZ) (Middle Region) Peptide (ABIN5511601)
Target
TAZ
(Tafazzin (TAZ))
Origin
Human
Source
Synthetic
Application
Blocking Peptide (BP), Western Blotting (WB)
-
-
Protein Region
- Middle Region
-
Sequence
- LHSHFFSLGK CVPVCRGAEF FQAENEGKGV LDTGRHMPGA GKRREKGDGV
-
Characteristics
- This is a synthetic peptide designed for use in combination with anti-TAZ Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
-
Tafazzin (TAZ) peptide
TAZ Reactivity: Human, Mouse, Rat, Dog Host: Synthetic BP, Imm
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- TAZ (Tafazzin (TAZ))
-
Background
-
This gene encodes a protein that is expressed at high levels in cardiac and skeletal muscle. Mutations in this gene have been associated with a number of clinical disorders including Barth syndrome, dilated cardiomyopathy (DCM), hypertrophic DCM, endocardial fibroelastosis, and left ventricular noncompaction (LVNC). Multiple transcript variants encoding different isoforms have been described. A long form and a short form of each of these isoforms is produced, the short form lacks a hydrophobic leader sequence and may exist as a cytoplasmic protein rather than being membrane-bound. Other alternatively spliced transcripts have been described but the full-length nature of all these transcripts is not known.
Alias Symbols: TAZ,EFE2,G4.5,
Protein Size: 292 -
Gene ID
- 6901
-
UniProt
- Q16635
Target
-
You are here:
